Roche
Roche is a global leader in biotechnology and in-vitro diagnostics, committed to innovative healthcare solutions and sustainability, with significant investments in R&D and a unique structure combining diagnostics and pharmaceuticals.
Company Overview
Roche is one of the world’s largest biotech companies and a leading provider of in-vitro diagnostics. Founded over 125 years ago, Roche has been developing innovative solutions for a wide range of chronic and life-threatening health conditions. The company has a unique structure that combines expertise in both diagnostics and pharmaceuticals, setting it apart in the industry. Headquartered in Basel, Switzerland, Roche is a global leader in healthcare, partnering with many forward-thinking, entrepreneurial, and groundbreaking organizations.
Pharmaceutical and Diagnostics Divisions
Roche operates two major divisions: Pharmaceuticals and Diagnostics. In 2023, the Pharmaceuticals Division recorded sales of CHF 44.6 billion, while the Diagnostics Division reported sales of CHF 14.1 billion. The company also invested CHF 13.2 billion in research and development to further its innovation goals. Roche’s approach combines pharmaceutical and diagnostic expertise with expanded data science capabilities, contributing to breakthrough research and development.
Sustainability and Environmental Commitments
Roche is deeply committed to sustainability, aiming to halve the environmental impact of its operations and products from 2019 to 2029. The company’s sustainability strategy integrates society, environment, and economy dimensions. Roche has set an ambitious target to achieve absolute zero greenhouse gas emissions by 2050. The eco-balance metric is used to measure and continuously strive to lower the environmental impact by consuming less energy, reducing emissions, using less water, and producing less waste.
Global Initiatives and Programs
Roche runs several global initiatives aimed at improving healthcare and diagnostics across the world. The Global Access Program trains lab technicians in Africa to address critical shortages and enhance the quality of diagnostic services. In the Changing Diabetes in Children program, Roche has reached 29 countries since its launch in 2009. Other initiatives include the #MyStoryForChange campaign, which collected over 630 stories to address disparities in women's healthcare, and the HPV high-risk testing program, which reached over 600,000 women in low- and middle-income countries in 2023.
Innovation and Partnerships
Roche boasts innovation centers in 17 countries, forming a strong network of external partners driving creativity and innovation. The company’s partnerships and collaborations enable it to achieve breakthrough research and development. Notable partnerships include the initiative with Greenstar Social Marketing in Pakistan to improve diabetes management for women and the City Cancer Challenge active in 14 cities worldwide, reaching an estimated 66.5 million people. These collaborations exemplify Roche’s commitment to leveraging external expertise and creativity to drive advancements in healthcare.